Within the coming weeks, Americans will begin to consider critical issues concerning the future of health care for themselves and their children, including universal coverage, taxation of benefits, computerized records and the controlling of costs. But before the debate commences in Congress and the media, big insurance and pharmaceutical companies are lobbying frantically (and spending millions of dollars) to foreclose the possibility of the most promising aspect of health care reform: a public insurance option.